Literature DB >> 21207179

Nissen fundoplication after failure of endoluminal fundoplication: short-term results.

Uberto Fumagalli Romario1, Roberta Barbera, Alessandro Repici, Matteo Porta, Alberto Malesci, Riccardo Rosati.   

Abstract

BACKGROUND: Endoluminal fundoplication (ELF) with EsophyX is a new attractive investigational procedure for the control of gastroesophageal reflux disease (GERD). The aim of this work is to evaluate the short-term results of Nissen fundoplication (NF) after failure of ELF.
METHOD: During the period April 2007-January 2010, nine patients previously treated with ELF for GERD were submitted to laparoscopic NF for persistent reflux.
RESULTS: All patients were symptomatic for GERD, had a pathological esophageal acid exposure at multichannel intraluminal impedance (MII pH/24 h), and all of them were on proton pump inhibitor. Mean duration of the NF was 85 min (range, 56-104). There were no intraoperative complications. One patient had a postoperative mild peritoneal bleeding treated conservatively. After a mean follow-up of 24.9 months (4-34), all patients are asymptomatic for reflux. Two patients have a mild or moderate dysphagia at follow-up. Five patients underwent MII pH/24 h 1 year after surgery. Mean total reflux time was 0.3%, and acid reflux percent time was 0.
CONCLUSIONS: Patients with persistent symptomatic reflux after a failing ELF can still undergo NF with good results; the endoluminal procedure does not seem to modify the results of the laparoscopic procedure, although an increased incidence of dysphagia pos-NF may be observed.

Entities:  

Mesh:

Year:  2011        PMID: 21207179     DOI: 10.1007/s11605-010-1409-2

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  18 in total

1.  Endoscopic full-thickness plication for the treatment of GERD: 12-month follow-up for the North American open-label trial.

Authors:  Douglas Pleskow; Richard Rothstein; Simon Lo; Robert Hawes; Richard Kozarek; Gregory Haber; Christopher Gostout; Anthony Lembo
Journal:  Gastrointest Endosc       Date:  2005-05       Impact factor: 9.427

2.  Ten-year outcome of laparoscopic antireflux surgery.

Authors:  M Fein; M Bueter; A Thalheimer; V Pachmayr; J Heimbucher; S M Freys; K-H Fuchs
Journal:  J Gastrointest Surg       Date:  2008-09-03       Impact factor: 3.452

3.  Effects of prior endoluminal gastroplication on subsequent laparoscopic Nissen fundoplication.

Authors:  B Tierney; A Iqbal; M Haider; C Filipi
Journal:  Surg Endosc       Date:  2007-01-06       Impact factor: 4.584

4.  Symptomatic and objective results of laparoscopic Nissen fundoplication after failed EndoCinch gastroplication for gastro-oesophageal reflux disease.

Authors:  Edgar J B Furnée; Joris A J L Broeders; Werner A Draaisma; Matthijs P Schwartz; Eric J Hazebroek; André J P M Smout; Ivo A M J Broeders
Journal:  Eur J Gastroenterol Hepatol       Date:  2010-09       Impact factor: 2.566

5.  Endoluminal fundoplication (ELF) for GERD using EsophyX: a 12-month follow-up in a single-center experience.

Authors:  Alessandro Repici; Uberto Fumagalli; Alberto Malesci; Roberta Barbera; Camilla Gambaro; Riccardo Rosati
Journal:  J Gastrointest Surg       Date:  2009-11-10       Impact factor: 3.452

6.  Long-term outcomes of quality of life after laparoscopic Nissen fundoplication.

Authors:  J P Araújo Teixeira; V Mosquera; A Flores
Journal:  Hepatogastroenterology       Date:  2009 Jan-Feb

7.  Effect of transoral incisionless fundoplication on symptoms, PPI use, and ph-impedance refluxes of GERD patients.

Authors:  Pier Alberto Testoni; Maura Corsetti; Salvatore Di Pietro; Antonio Gianluca Castellaneta; Cristian Vailati; Enzo Masci; Sandro Passaretti
Journal:  World J Surg       Date:  2010-04       Impact factor: 3.352

Review 8.  Systematic review of endoscopic treatments for gastro-oesophageal reflux disease.

Authors:  D Chen; C Barber; P McLoughlin; P Thavaneswaran; G G Jamieson; G J Maddern
Journal:  Br J Surg       Date:  2009-02       Impact factor: 6.939

Review 9.  Endoluminal GERD treatments: critical appraisal of current literature with evidence-based medicine instruments.

Authors:  Alfonso Torquati; William O Richards
Journal:  Surg Endosc       Date:  2007-03-31       Impact factor: 3.453

10.  Comparing laparoscopic antireflux surgery with esomeprazole in the management of patients with chronic gastro-oesophageal reflux disease: a 3-year interim analysis of the LOTUS trial.

Authors:  L Lundell; S Attwood; C Ell; R Fiocca; J-P Galmiche; J Hatlebakk; T Lind; O Junghard
Journal:  Gut       Date:  2008-05-09       Impact factor: 23.059

View more
  3 in total

1.  The LINX® reflux management system: confirmed safety and efficacy now at 4 years.

Authors:  John C Lipham; Tom R DeMeester; Robert A Ganz; Luigi Bonavina; Greta Saino; Daniel H Dunn; Paul Fockens; Willem Bemelman
Journal:  Surg Endosc       Date:  2012-04-27       Impact factor: 4.584

Review 2.  Transoral incisionless fundoplication for gastro-esophageal reflux disease: Techniques and outcomes.

Authors:  Pier Alberto Testoni; Giorgia Mazzoleni; Sabrina Gloria Giulia Testoni
Journal:  World J Gastrointest Pharmacol Ther       Date:  2016-05-06

3.  Comprehensive evaluation of endoscopic fundoplication using the EsophyX™ device.

Authors:  Rebecca P Petersen; Laura Filippa; Eelco B Wassenaar; Ana V Martin; Roger Tatum; Brant K Oelschlager
Journal:  Surg Endosc       Date:  2011-11-01       Impact factor: 4.584

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.